Category: <span>mesothelioma</span>

Controversial Ohio Senate Bill Could Complicate Asbestos Lawsuits

Republican Ohio State Senator George F. Lang is the primary sponsor of a controversial senate bill poised to impact people diagnosed with mesothelioma. The bill would require plaintiffs to supply personal and specific information within 30 days of filing a lawsuit or risk the suit being dismissed.  Cosponsors of SB63 include OH State Senators Jerry […]

The post Controversial Ohio Senate Bill Could Complicate Asbestos Lawsuits appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone

Results of a new phase 3 clinical trial published in the Journal of Clinical Oncology indicate that a chemoimmunotherapy regimen combining chemotherapy with immunotherapy drugs improves patient survival more than chemotherapy alone for pleural mesothelioma. Study researchers used pembrolizumab (Keytruda) alongside platinum and pemetrexed chemotherapy. Christina S. Baik, MD, MPH, reviewed the phase 3 trial […]

The post Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Toxic Ash Threatens Health During Maui Lahaina Wildfire Cleanup

Health officials are warning Maui residents to exercise caution during cleanup following deadly wildfires as ash and debris may be filled with toxic substances, including asbestos, arsenic and lead. The aftermath of the Aug. 8 fire on the Hawaiian island has left a hazardous trail of pollutants and destruction after it decimated the historical coastal […]

The post Toxic Ash Threatens Health During Maui Lahaina Wildfire Cleanup appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma Baby Powder Lawsuit Costs J&J $18.8 Million

A jury has ruled that Johnson & Johnson must pay $18.8 million in monetary damages to a California man who developed mesothelioma after long-time exposure to the company’s talc-based baby powder. The decision was made following a six-week trial, the first centered around talcum powder that J&J has encountered in nearly two years. This comes […]

The post Mesothelioma Baby Powder Lawsuit Costs J&J $18.8 Million appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Phase 3 Keytruda, Chemotherapy Mesothelioma Trial Shows Promising Results

Pharmaceutical company Merck says use of its immunotherapy drug Keytruda in conjunction with chemotherapy increases the survival rate for people with advanced pleural mesothelioma, according to the latest results of a phase 3 clinical trial. The results were announced in June at the annual meeting of the American Society of Clinical Oncology. They showed Merck’s […]

The post Phase 3 Keytruda, Chemotherapy Mesothelioma Trial Shows Promising Results appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

UK Parliament, Riddled With Asbestos, Faces Restoration Delays

Lawmakers say that Britain’s Palace of Westminster is at risk of demolition because the iconic and historic structure needs several costly repairs, including asbestos removal. Nearly 120 workers and other people inside the palace were potentially exposed to asbestos during a 2022 renovation in the speaker’s residential space. In addition to asbestos and its cancer […]

The post UK Parliament, Riddled With Asbestos, Faces Restoration Delays appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Canadian Government Creates New Asbestos Abatement Rules

Beginning in January 2024, the Canadian province of British Columbia will be the first in that country to require asbestos abatement companies to have government-issued licenses to work. Canadian workers’ compensation statutory agency WorkSafeBC is developing requirements companies must meet to become fully licensed in the safe removal of asbestos. Canada banned asbestos in 2018, […]

The post Canadian Government Creates New Asbestos Abatement Rules appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

CARD Clinic in Libby Designated as Center of Excellence   

Lawmakers in Montana have declared the Center for Asbestos Related Diseases, also known as the CARD Clinic, as a Center of Excellence. The Montana House of Representatives passed a resolution in May 2023 recognizing the clinic’s importance. Lawmakers say the clinic based in Libby, Montana, played a significant role in an asbestos contamination Superfund that […]

The post CARD Clinic in Libby Designated as Center of Excellence    appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Australian Asbestos Ghost Town Cemetery Raises Questions

Western Australia’s most notorious ghost town known for widespread asbestos contamination and mesothelioma has been razed. But loved ones wonder how they can visit family and friends buried in the town’s cemetery. Demolition of the abandoned town of Wittenoom had begun in May after a brush fire in late 2022 destroyed the town’s few remaining […]

The post Australian Asbestos Ghost Town Cemetery Raises Questions appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New UMD Study Shows How Mesothelioma Can Spread

Researchers at the University of Maryland are getting a better idea of why mesothelioma takes decades to develop in the body. In a 2023 paper published in the journal Environmental Research, a team of researchers at the University of Maryland found that understanding mesothelioma involves the way immune cells “sense” and interact with particles around […]

The post New UMD Study Shows How Mesothelioma Can Spread appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Patients Needed for New Mesothelioma Clinical Trial

A new investigational drug for mesothelioma can now begin human trials after it was granted fast-track designation by the U.S. Food and Drug Administration last week. The novel treatment, SnyKIR-110, is a T-cell therapy designed to treat patients with mesothelioma, cholangiocarcinoma (bile duct cancer) and ovarian cancer.  “We are thrilled to receive fast-track designation from […]

The post Patients Needed for New Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Bill to Ban Asbestos Reintroduced by Oregon Legislators

Two Oregon legislators have reintroduced a bill to end the importation of asbestos, a known carcinogen banned in nearly 70 other countries. The bill would amend the Toxic Substances Control Act of 1976 and ban asbestos in the United States.  The Alan Reinstein Ban Asbestos Now Act of 2023, first introduced in 2019, was reintroduced […]

The post Bill to Ban Asbestos Reintroduced by Oregon Legislators appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New BAP1 Finding Could Be Key to Regulating Mesothelioma

Mesothelioma is a rare cancer most often caused by exposure to asbestos fibers. Our researchers at the University of Hawaii Cancer Center have discovered how asbestos causes mesothelioma, which we linked mainly to the protein HMGB1.  After several years of studying a unique mesothelioma epidemic in Cappadocia, Turkey, we noted that in certain families, up […]

The post New BAP1 Finding Could Be Key to Regulating Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Netherlands Cancer Institute Tests New Mesothelioma Therapy

Research for a new type of mesothelioma treatment is underway at the Netherlands Cancer Institute. Scientists are exploring a novel combination of existing medications for patients with BAP1 genetic mutations.  More than half of all mesothelioma patients show alterations in the BAP1 tumor-suppressor gene. An altered BAP1 gene allows for vulnerabilities that make specific treatments […]

The post Netherlands Cancer Institute Tests New Mesothelioma Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Court Rejects Johnson & Johnson’s Bankruptcy Plan for Talc Lawsuits

A federal appeals court last week rejected an LTL Management bankruptcy filing, delivering a blow to the company’s plan to resolve thousands of talc lawsuits. The company is a Johnson & Johnson subsidiary. The ruling effectively found the company’s bankruptcy was not filed in good faith. J&J said on Feb. 6 that it plans to […]

The post Court Rejects Johnson & Johnson’s Bankruptcy Plan for Talc Lawsuits appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.